Earnings
BIOL
0.2930
+2.27%
0.0065
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
5.79M
--
--
8.76M
--
--
0.00
--
10.99M
--
1.16M
312.00K
27.02M
1.47M
--
--
--
2.93M
0.00
--
433.00K
4.83M
31.85M
--
5.33M
13.47M
--
--
--
--
--
3.79M
--
--
--
3.19M
25.78M
0.00
--
--
78.00K
1.65M
1.73M
27.50M
31.00K
235.59M
-234.55M
--
--
--
4.34M
4.34M
31.85M
FY 2018-12-31
8.04M
--
--
10.99M
--
--
122.00K
--
12.25M
--
1.59M
312.00K
33.31M
1.98M
--
--
--
2.93M
0.00
--
308.00K
5.21M
38.52M
--
5.95M
0.00
--
--
--
--
--
6.13M
--
--
--
3.88M
15.97M
10.84M
--
--
77.00K
547.00K
11.46M
27.43M
21.00K
228.43M
-216.69M
--
--
--
11.09M
11.09M
38.52M
FY 2017-12-31
11.64M
--
--
10.05M
--
--
77.00K
--
12.30M
--
1.73M
251.00K
36.05M
3.67M
--
--
--
2.93M
0.00
--
334.00K
6.93M
42.98M
--
5.11M
0.00
--
--
--
--
--
4.69M
--
--
--
3.57M
13.37M
0.00
--
--
104.00K
250.00K
354.00K
13.72M
102.00K
224.91M
-195.18M
--
--
--
29.26M
29.26M
42.98M
FY 2016-12-31
8.92M
--
--
9.70M
--
--
85.00K
--
13.52M
--
1.50M
251.00K
33.99M
4.48M
--
--
--
2.93M
0.00
--
550.00K
7.95M
41.94M
--
9.13M
0.00
--
--
--
--
--
4.77M
--
--
--
3.96M
18.01M
0.00
--
--
798.00K
1.06M
1.86M
19.88M
68.00K
201.20M
-178.32M
--
--
--
22.07M
22.07M
41.94M
FY 2015-12-31
11.70M
--
--
8.85M
--
--
98.00K
--
12.57M
--
1.39M
200.00K
34.80M
3.73M
--
--
--
2.93M
51.00K
--
747.00K
7.45M
42.25M
--
5.96M
0.00
--
--
--
--
--
4.80M
--
--
--
4.18M
15.11M
159.00K
--
--
738.00K
1.32M
2.22M
17.33M
58.00K
188.62M
-162.95M
--
--
--
24.93M
24.93M
42.25M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out BIOL latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze BIOLASE recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.